Clinical Trials

NCT06364514 | RECRUITING | NA
50 Participants

PICNIC Study - PatIent Centered aNtIbiotic Courses in Children With Medical Complexity

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-08-20
Completion: 2026-06-01
Conditions
Pneumonia
Interventions
OTHER
No Results Yet
NCT06364228 | RECRUITING | PHASE2
32 Participants

Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2026-01-05
Completion: 2027-02-28
Conditions
Stress
Interventions
DRUG PROCEDURE
No Results Yet
NCT06356220 | RECRUITING | NA
120 Participants

GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-04-29
Completion: 2026-05-31
Conditions
Celiac Disease in Children Nutrition Disorder, Child
Interventions
OTHER
No Results Yet
NCT06353386 | RECRUITING | PHASE1/PHASE2
220 Participants

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-05-20
Completion: 2029-01-15
Conditions
Prostatic Neoplasms, Castration-Resistant
Interventions
DRUG
No Results Yet
NCT06351644 | TERMINATED | PHASE1/PHASE2
2 Participants

ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-10-02
Completion: 2025-04-28
Conditions
Relapsed and/or Refractory Multiple Myeloma
Interventions
DRUG
No Results Yet
NCT06342986 | RECRUITING | PHASE1
33 Participants

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-07-11
Completion: 2026-12-31
Conditions
Gynecologic Cancer Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cavity Cancer
Interventions
DRUG
No Results Yet
NCT06338748 | ACTIVE_NOT_RECRUITING | NA
28 Participants

Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-11-02
Completion: 2025-10-01
Conditions
Continuous Glucose Monitoring
Interventions
DEVICE
No Results Yet
NCT06335303 | ACTIVE_NOT_RECRUITING | PHASE2
322 Participants

A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-09-05
Completion: 2025-11-14
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG
No Results Yet
NCT06333860 | ACTIVE_NOT_RECRUITING | PHASE4
393 Participants

A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-05-10
Completion: 2026-03-31
Conditions
Moderate Plaque Psoriasis
Interventions
DRUG
No Results Yet
NCT06333652 | RECRUITING | PHASE2
14 Participants

Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2026-03-01
Completion: 2026-12-31
Conditions
Preeclampsia
Interventions
DRUG
No Results Yet
NCT06325683 | RECRUITING | PHASE2
184 Participants

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-11-08
Completion: 2028-07-15
Conditions
Progressive Glioblastoma Recurrent Glioblastoma
Interventions
PROCEDURE DRUG BIOLOGICAL
No Results Yet
NCT06324357 | RECRUITING | PHASE1/PHASE2
582 Participants

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-06-03
Completion: 2029-09-28
Conditions
Metastatic Breast Cancer Metastatic Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma
Interventions
DRUG
No Results Yet
NCT06317662 | RECRUITING | PHASE2
153 Participants

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-06-05
Completion: 2028-12-31
Conditions
Acute Leukemia of Ambiguous Lineage B Acute Lymphoblastic Leukemia
Interventions
DRUG PROCEDURE BIOLOGICAL
No Results Yet
NCT06317649 | RECRUITING | PHASE2
147 Participants

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-09-27
Completion: 2025-10-31
Conditions
Acute Myeloid Leukemia
Interventions
DRUG PROCEDURE
No Results Yet
NCT06317285 | TERMINATED | PHASE2
158 Participants

A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-04-04
Completion: 2025-10-01
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG
No Results Yet
NCT06287775 | RECRUITING | PHASE1/PHASE2
45 Participants

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-04-08
Completion: 2029-07-25
Conditions
Extensive Stage Lung Small Cell Carcinoma Stage IV Lung Cancer AJCC v8
Interventions
BIOLOGICAL PROCEDURE DRUG
No Results Yet
NCT06286033 | RECRUITING | PHASE1
112 Participants

Single and Multiple Ascending Dose Study and Food Effect Study for AG181

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-02-20
Completion: 2026-03-31
Conditions
Healthy Volunteers
Interventions
DRUG
No Results Yet
NCT06283394 | ACTIVE_NOT_RECRUITING | NA
224 Participants

Penn Medicine Food Market Study

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-08-01
Completion: 2025-05-01
Conditions
Obesity Diabetes
Interventions
BEHAVIORAL
No Results Yet
NCT06257628 | WITHDRAWN
0 Participants

MACE CDS Software Master Enrollment Protocol

Study Type: OBSERVATIONAL
Last Updated: 2025-11-12
Start Date: 2023-09-14
Completion: 2025-05-31
Conditions
Cardiac Events
Interventions
DEVICE
No Results Yet
NCT06254326 | ACTIVE_NOT_RECRUITING | PHASE1
12 Participants

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-09-19
Completion: 2027-12-31
Conditions
Recurrent Oligodendroglioma Progressive Oligodendroglioma
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT06246110 | RECRUITING | PHASE2
70 Participants

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-02-06
Completion: 2026-12-31
Conditions
NSCLC
Interventions
DRUG
No Results Yet
NCT06227026 | RECRUITING | PHASE1
10 Participants

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-02-20
Completion: 2026-01-15
Conditions
Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma
Interventions
BIOLOGICAL
No Results Yet
NCT06226805 | RECRUITING | PHASE2
156 Participants

Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-07-31
Completion: 2027-06-30
Conditions
Acute Ischemic Stroke
Interventions
DRUG
No Results Yet
NCT06223555 | RECRUITING | NA
79 Participants

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-08-23
Completion: 2026-06-30
Conditions
Obesity Healthy Volunteer
Interventions
OTHER
No Results Yet
NCT06215118 | RECRUITING | PHASE1
87 Participants

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-02-20
Completion: 2027-04-10
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
NCT06214741 | ACTIVE_NOT_RECRUITING | PHASE3
307 Participants

A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-02-06
Completion: 2025-07-29
Conditions
Obesity Overweight
Interventions
DRUG
No Results Yet
NCT06212752 | ACTIVE_NOT_RECRUITING | PHASE3
39 Participants

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2023-06-13
Completion: 2024-11-06
Conditions
Metastatic Non-small Cell Lung Cancer
Interventions
BIOLOGICAL DRUG
NCT06206746 | RECRUITING | NA
195 Participants

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-03-25
Completion: 2026-06-30
Conditions
Polycystic Ovary Syndrome Infertility, Female
Interventions
DEVICE
No Results Yet
NCT06195306 | RECRUITING | PHASE2
66 Participants

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-04-01
Completion: 2027-10-01
Conditions
Breast Atypical Hyperplasia Breast Carcinoma Breast Ductal Carcinoma In Situ Breast Lobular Carcinoma In Situ
Interventions
PROCEDURE DRUG OTHER
No Results Yet
NCT06192160 | RECRUITING | PHASE2
315 Participants

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2025-03-11
Completion: 2026-11-11
Conditions
Pulmonary Tuberculosis
Interventions
DRUG
No Results Yet
NCT06191484 | RECRUITING | NA
169 Participants

Risk and Resilience to Suicide Following Late-Life Spousal Bereavement

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2023-11-20
Completion: 2028-12-31
Conditions
Suicide Bereavement
Interventions
BEHAVIORAL
No Results Yet
NCT06189807 | ACTIVE_NOT_RECRUITING | NA
70 Participants

Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-02-14
Completion: 2025-09-24
Conditions
CKD Chronic Kidney Diseases
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT06176365 | ACTIVE_NOT_RECRUITING | PHASE3
274 Participants

A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-01-16
Completion: 2025-12-03
Conditions
Obesity
Interventions
DRUG
No Results Yet
NCT06173804 | ACTIVE_NOT_RECRUITING | NA
20 Participants

Multilevel Lifestyle Intervention to Improve Physical Function in Older Adults With Type 2 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-07-22
Completion: 2025-05-23
Conditions
Type 2 Diabetes
Interventions
OTHER
No Results Yet
NCT06172296 | RECRUITING | PHASE3
478 Participants

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-04-19
Completion: 2029-12-31
Conditions
Ganglioneuroblastoma, Nodular Neuroblastoma
Interventions
PROCEDURE DRUG BIOLOGICAL RADIATION OTHER
No Results Yet
NCT06164951 | ACTIVE_NOT_RECRUITING | PHASE3
110 Participants

A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2023-11-10
Completion: 2025-12-31
Conditions
Achondroplasia
Interventions
DRUG
No Results Yet
NCT06152575 | RECRUITING | PHASE3
492 Participants

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-02-08
Completion: 2026-08-30
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
NCT06150417 | RECRUITING | PHASE2
200 Participants

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2024-07-01
Completion: 2028-04-01
Conditions
Prostate Cancer Malignant Neoplasm of Prostate Secondary Malignant Neoplasm of Prostate
Interventions
DRUG OTHER RADIATION
No Results Yet
NCT06139328 | ACTIVE_NOT_RECRUITING | PHASE2
160 Participants

IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

Study Type: INTERVENTIONAL
Last Updated: 2025-11-12
Start Date: 2023-12-05
Completion: 2025-09-02
Conditions
Myocardial Infarction
Interventions
DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page ยท Total 557286 trials